SEC
Filings

SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	View
Nov 07, 2013	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001144204-13-059648.pdf 0001144204-13-059648.rtf 0001144204-13-059648.xls
Nov 07, 2013	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0001144204-13-059676.pdf 0001144204-13-059676.rtf 0001144204-13-059676.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Nov 07, 2013	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001144204-13-059675.pdf 0001144204-13-059675.rtf 0001144204-13-059675.xls
Nov 07, 2013	425	Filing of certain prospectuses and communications in connection with business combination transactions	Other	View HTML 0001144204-13-059677.pdf 0001144204-13-059677.rtf 0001144204-13-059677.xls
Nov 04, 2013	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001144204-13-058597.pdf 0001144204-13-058597.rtf 0001144204-13-058597.xls
Nov 04, 2013	425	Filing of certain prospectuses and communications in connection with business combination transactions	Other	View HTML 0001144204-13-058598.pdf 0001144204-13-058598.rtf 0001144204-13-058598.xls
Oct 31, 2013	CT ORDER	CT ORDER	Other	View HTML 9999999997-13-016097.pdf
Oct 30, 2013	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001144204-13-057501.pdf 0001144204-13-057501.rtf 0001144204-13-057501.xls
Oct 30, 2013	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001144204-13-057680.pdf 0001144204-13-057680.rtf
Oct 29, 2013	EFFECT	EFFECT	Other	View HTML 9999999995-13-003102.pdf 9999999995-13-003102.rtf 9999999995-13-003102.xls

Data provided by Kaleidoscope.

Investor Contact

Email: ir@altimmune.com

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

© 2025 Altimmune. All rights reserved.